IOVANCE BIOTHERAPEUTICS, INC. (IOVA) › Cost of RevenueIOVANCE BIOTHERAPEUTICS, INC. (IOVA) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2023: $1.03M2024: $93.25M2025: $173.18M$173.18M2023Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$173.18M+85.7%2024$93.25M+8926.9%2023$1.03M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share